Giant Cell Arteritis
Giant Cell Arteritis
Contact Us
Related Videos :
Frequently Asked Questions (FAQ) :
1. Can Giant Cell Arteritis cause permanent vision loss?
Yes, if left untreated, GCA can lead to permanent vision loss. Early diagnosis and treatment are crucial to prevent this complication.
2. Is Giant Cell Arteritis curable?
While there is no cure for GCA, it can be managed effectively with medications, primarily corticosteroids, to control inflammation and prevent complications.
3. How quickly does vision loss occur in GCA?
Vision loss can happen suddenly and progress rapidly. That’s why it’s vital to seek immediate medical attention if you experience any vision changes.
About Giant Cell Arteritis
Giant Cell Arteritis (GCA), also known as temporal arteritis, is a condition that causes inflammation of the blood vessels, particularly the arteries in the head and neck. This inflammation can lead to serious complications, including vision loss. GCA is most commonly seen in people over the age of 50, and early diagnosis and treatment are crucial to prevent permanent damage.
As an ophthalmologist, Dr. Suraj Munjal specializes in the diagnosis and management of conditions like GCA, which can affect your vision if left untreated.
Causes of Giant Cell Arteritis
The exact cause of GCA is not fully understood, but it is thought to be an autoimmune response where the body’s immune system mistakenly attacks the walls of healthy blood vessels. Some factors that may contribute to the development of GCA include:
- Age: Most commonly affects people over 50.
- Gender: Women are more prone to developing GCA than men.
- Genetics: A family history of GCA or other autoimmune diseases can increase your risk.
- Infection: Some infections might trigger the immune response leading to GCA.
Types of Giant Cell Arteritis
Giant Cell Arteritis is primarily divided into two types:
- Cranial Giant Cell Arteritis: Affects the blood vessels in the scalp and temples.
- Large-Vessel Giant Cell Arteritis: Involves larger arteries, such as those in the chest and neck.
Both forms can lead to serious health issues, including vision loss, if not treated promptly.
Symptoms of Giant Cell Arteritis
Symptoms of GCA can vary, but the most common include:
- Severe headache, particularly around the temples
- Scalp tenderness
- Jaw pain while chewing
- Sudden vision problems (blurred vision, double vision, or loss of vision)
- Fatigue
- Fever
- Unexplained weight loss
Diagnosis of Giant Cell Arteritis
Early and accurate diagnosis of GCA is vital to prevent complications like permanent vision loss. Dr. Suraj Munjal may use the following tests to diagnose GCA:
- Blood Tests: Elevated markers of inflammation such as ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein).
- Temporal Artery Biopsy: A small sample of the temporal artery is taken and examined under a microscope to detect inflammation.
- Ultrasound or MRI: These imaging techniques help visualize inflamed arteries.
Treatment of Giant Cell Arteritis
The main goal of treatment for GCA is to reduce inflammation and prevent complications like vision loss. Treatment usually involves:
- Corticosteroids: These are the first-line treatment to quickly reduce inflammation.
- Immunosuppressive Medications: In cases where corticosteroids are not enough or cause side effects, medications like methotrexate may be prescribed.
- Regular Monitoring: Ongoing medical care is essential to monitor the disease and adjust treatment as needed.
Cost of Treatment and Stay in India
India is becoming a leading destination for affordable medical care. Dr. Suraj Munjal’s clinic offers world-class treatment for Giant Cell Arteritis at a fraction of the cost compared to Western countries. Here’s what you can expect:
- Cost of Treatment: The cost varies depending on the severity of the condition and the required medical care. It can range from $2000 to $5000 USD for comprehensive treatment.
- Stay in India: Patients may need to stay in India for 1-2 weeks for diagnosis, treatment, and follow-up care. India offers affordable accommodations, making it a cost-effective option for international patients.